The Antibody Drug Conjugate Market is integrating combinatorial approaches with immunotherapy by combining ADCs with checkpoint inhibitors, CAR-T cell therapy, and other immunotherapies to enhance anti-tumor immune responses and overcome resistance mechanisms. Combination strategies are showing promise in clinical trials.
One of the main applications is ADC plus checkpoint inhibitor...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
china 
thai
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)